SCHEMBL18157750

SCHEMBL18157750

Cc1ccc(/C=C/c2[nH]c3ccccc3c2/C=C/c2ccc(F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 7/20 0.53
MAPT P10636 9/20 0.47
MEN1 O00255 8/20 0.47
KMT2A Q03164 8/20 0.47
ALDH1A1 P00352 6/20 0.47
RAB9A P51151 5/20 0.47
NPC1 O15118 4/20 0.47
NPSR1 Q6W5P4 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
ALPG P10696 1/20 0.47
HTT P42858 1/20 0.47
KDM4E B2RXH2 5/20 0.46
GAA P10253 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
GLA P06280 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
POLB P06746 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18160287 1.00 NFE2L2 (0.53) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18160168 0.93 ALDH1A1 (0.51) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18160143 0.93 MAPT (0.52) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18157735 0.90 NPC1 (0.50) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18160289 0.90 NFE2L2 (0.55) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18160186 0.90 NPC1 (0.50) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18157733 0.90 NFE2L2 (0.55) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18157758 0.89 NFE2L2 (0.61) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18180638 0.86 MAPT (0.46) NFE2L2MAPTMEN1KMT2AALDH1A1
SCHEMBL18157738 0.86 MAPT (0.47) MAPTMEN1KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD NFE2L2 220/4885MAPT 2538/4885MEN1 1398/4885
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD NFE2L2 220/4885MAPT 2538/4885MEN1 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.